English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Veterinary Vaccine Reassortant Avian Influenza Virus H5 Vaccine Inactivated Vaccine (Cell Source, H5N6 Strain H5-Re13+H5N8 H5-Re14) for Bird Use
Description
Basic Info
| Model NO. | H5 Vaccine |
| Varieties | General Disease Prevention Medicine |
| Component | Virus |
| Type | The First Class |
| Pharmacodynamic Influential Factors | Temperature |
| Storage Method | 2-8°c |
| Veterinary Reg. No. | 153122266 |
| Characteristic | Milky in Colour, Water in Oil Emulsion |
| Adverse Effect | None |
| Shelf Life | 12 Months |
| Storage | 2-8 |
| Package | 20ml*200 Bottle/Carton |
| Transport Package | Bottle |
| Specification | 250ml/bottle, 500ml/bottle |
| Trademark | SINDER |
| Origin | Zhucheng City, China |
| HS Code | 3002300000 |
| Production Capacity | 100000L/Year |
Product Description
Reassortant Avian Influenza Virus (H5 Vaccine) Bivalent Vaccine, Inactivated (Cell Source, H5N6 Strain H5-Re13+H5N8 H5-Re14)
For Veterinary Use Only
(Generic name) Reassortant Avian Influenza Virus (H5 Vaccine) Bivalent Vaccine, Inactivated (Cell Source, H5N6 Strain H5-Re13+H5N8 H5-Re14)
(Main Components and Content) The vaccine contains inactivated Reassortant Avian Influenza Virus H5N6 Subtype, Strain H5 Re-13 and H5N8 Subtype, Strain H5 Re-14 proliferated by MDCK cells. The HA Titers before inactivation were 1:256.
(Physical Property) White milky emulsion
(Indication for Use) For prevention of avian influenza H5 subtype 2.3.4.4h branch and 2.3.4.4b branch. Immunity will be produced after 14 days of vaccination, and the immune period of chickens will be 6 months. One more booster for ducks and geese after first administration, the immune period will be 4 months.
(Administration and Dosage)
To be injected intramuscularly or subcutaneously at the neck area. At a dosage of 0.3 ml for chickens at 14-35 days old, 0.5 ml for chickens older than 35 days.Also, at a dosage of 0.5ml for ducks and geese at 14-35 days old and 1.0 ml for ducks and geese older than 35 days.
(Adverse Effects)No adverse effects generally if product used properly.
(Precautions)
1. Don't administer to Birds infected avian influenza virus or to unhealthy Birds.
2. Don't freeze the vaccine.
3. Don't use if you noticed any changes in physical appearance.
4. The vaccine temperature should be restored to room temperature and shake well before use.
5. Change syringe needles on time.
6. Once the bottle is open, the vaccine should be used out within 1 day.
7. Don't use within 28 days before slaughter
8. Used vaccine vials, utensils and unused vaccines should be treated harmlessly
(Packing Unit)(1) 250 ml/Bottle (2) 500 ml/Bottle
(Package)(1) 40 Bottles/Carton (2) 20 Bottles/Carton
(Storage and Validity)Store at 2-8ºC, Validity is 12 months from production date.
(China Registration Number Approval)Veterinary Drug 153122371.
(Manufacturer)Shandong Sinder Animal Vaccine
A Subsidiary of Shandong Sinder Technology
Country of Origin: China
Shandong Sinder Technology ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.
Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!
Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.
Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.
Our Contact
